AI in Medicine News ・ 💊 Drug discovery and clinical trials

Bristol Myers Squibb (BMY) Bets On AI Drug Discovery And Wider Trial Access

Yahoo Finance 🔗 Share link 10/24 01:09 UTC 🔗 Share link Pathos AI Raises $237M Series E at ~$3B Valuation, Led by Bristol Myers Squibb — Wowtale · 10/24 08:03 UTC

Bristol Myers Squibb (NYSE:BMY) has entered multi-year AI drug development partnerships with Pathos AI and Tempus AI. The agreement gives Bristol Myers Squibb exclusive access to Pathos AI.

Read the original (Yahoo Finance 🔗 Share link 10/24 01:09 UTC 🔗 Share link Pathos AI Raises $237M Series E at ~$3B Valuation, Led by Bristol Myers Squibb — Wowtale)

See it in the digest → ・ See this issue →